Adma Biologics (ADMA) Asset Utilization Ratio (2012 - 2025)

Adma Biologics has reported Asset Utilization Ratio for 12 years, with the latest figure at 0.86 in Q4 2025.

• For the quarter ending Q4 2025, Asset Utilization Ratio fell 11.82% year-over-year to 0.86; the trailing twelve-month figure through Dec 2025 stood at 0.86 (down 11.82% YoY), and the FY2025 full-year result was 0.92, down 12.09% from the prior year.
• Asset Utilization Ratio for Q4 2025 stood at 0.86, down from 0.87 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 1.03 in Q2 2024, with the low at 0.22 in Q1 2021.
• Historically, Asset Utilization Ratio has averaged 0.69 across 5 years, with a median of 0.74 in 2022.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 139.58% — and 2025, when it fell 13.5%.
• Adma Biologics' Asset Utilization Ratio stood at 0.43 in 2021, then jumped by 41.33% to 0.6 in 2022, then jumped by 47.56% to 0.89 in 2023, then grew by 9.29% to 0.97 in 2024, then slipped by 11.82% to 0.86 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.86 (Q4 2025), 0.87 (Q3 2025), and 0.89 (Q2 2025), per Business Quant data.